SU2C Scientific Research Teams

Share this:
Email

Like this page on Facebook

Peter A. Jones, Ph.D., D.Sc.

Scientific Research Team:
Bringing Epigenetic Therapy to the Forefront of Cancer Management

Peter A. Jones, Ph.D., D.Sc.

Dr. Jones was born in South Africa, raised and attended college in Rhodesia (now Zimbabwe), and received his Ph.D. from the University of London. He joined the University of Southern California in 1977, attaining the rank of Professor in 1985 and Distinguished Professor in 1999, and he was Director of the USC Norris Comprehensive Cancer Center between 1993 and 2011. His laboratory discovered the effects of 5-azacytidine on DNA methylation and linked this process to the activation of silenced genes. He is known for his studies on the molecular biology of cancer and of basic mechanisms of DNA methylation and its role in cancer and differentiation. He is a past President of the American Association for Cancer Research and was elected as a Fellow of the Academy of the AACR in 2013. He has published more than 300 scientific papers and received several honors, including the Outstanding Investigator Grant from the National Cancer Institute. He shared with Stephen Baylin the Kirk A. Landon Award for Basic Cancer Research from the AACR in 2009 and the Medal of Honor from the American Cancer Society in 2011. - See more at: http://www.vai.org/vari/research-programs/lab-for-cancer-epigenomics/lead-investigator-bio.aspx#sthash.12Ij4YTW.dpuf

Here we stand on the verge of unlocking the secrets that will end cancer. Donate Now.
A one percent reduction in cancer deaths would be worth $500 billion, almost 2.5 times what the U.S. spends each year on the disease.